It does this naturally with the light touch, but therapeutically proven intervention of super refined Melaleuca oil.
WOUNDAID is particularly relevant where micro-organisms are suspected of delaying healing, without incurring the expense and long term risks of using more fashionable heavy hitting antibacterial preparations.
Wound progress 13 days post initial treatment.
The active agents in WOUNDAID are carried in a physiologically compatible base that donates moisture to the wound bed and with the action of gentle surfactants, helps to lift wound debris that can be a barrier to healing.
WOUNDAID is easily removed at dressing changes to limit patient discomfort and won’t discolour the healing skin, to allow fast and objective wound assessment.
Rye Pharmaceuticals | Woundcare Supplies
For nearly 30 years Rye Pharmaceuticals has been researching and developing premium quality medical products in Australia, for distribution around the globe.
Our product range plays a central role to help clinicians and consumers to reduce trauma and aggravation for people with painful burns, open wounds and debilitating skin conditions.
Our mission is help these people recover quickly, allowing them to spend more time with loved ones and doing the activities they love with them.
Rye has a commitment to ensuring our range has the best of science at the core of product design. In use, the products facilitate the natural healing processes in a manner that is biocompatible and as physiologically compliant as possible.
We work in close collaboration with internationally recognised research facilities and annually fund a number of studies to test our products in the most stringent of circumstances.
All products are therefore guaranteed to perform as promised, with proven therapeutic benefits.